NCT07748923

Brief Summary

This comparative matched-cohort study aims to evaluate the diagnostic performance of contrast-enhanced photon-counting computed tomography (PCCT) for detecting small gastrointestinal lesions compared with energy-integrating detector dual-energy computed tomography (DECT). The study includes a prospectively enrolled PCCT cohort and a retrospectively identified DECT cohort. Endoscopy with histopathology serves as the reference standard. Primary evaluation focuses on lesion detection, with additional assessment of lesion characterization, image quality, quantitative imaging parameters, and interobserver agreement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,762

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 18, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 12, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

August 6, 2026

Completed
Last Updated

August 6, 2026

Status Verified

June 1, 2026

Enrollment Period

2.3 years

First QC Date

July 12, 2026

Last Update Submit

August 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lesion-Based Detection Rate

    Lesion-based detection rate of contrast-enhanced photon-counting CT compared with energy-integrating detector dual-energy CT using endoscopy with histopathology, when available, as the reference standard.

    During the study period (January 2026 - March 2026)

Secondary Outcomes (10)

  • Positive Predictive Value of CT-Positive Findings

    During the study period (March 2026 to June 2026)

  • Yield of Clinically Actionable Lesions

    During the study period (March 2026 to June 2026)

  • Lesion-to-Mucosa Attenuation Difference

    During the study period (January 2026 - March 2026)

  • Image Noise

    During the study period (January 2026 - March 2026)

  • Signal-to-Noise Ratio

    During the study period (January 2026 - March 2026)

  • +5 more secondary outcomes

Study Arms (3)

PCCT Diagnostic Cohort

Prospectively enrolled adults who underwent contrast-enhanced photon-counting computed tomography (PCCT) for evaluation of suspected small gastrointestinal lesions. Patients meeting the eligibility criteria were included in the diagnostic performance cohort and subsequently matched 1:1 with the retrospective DECT cohort using propensity score matching.

Diagnostic Test: Contrast-Enhanced Photon-Counting Computed Tomography

DECT Diagnostic Cohort

Retrospectively identified adults who underwent contrast-enhanced energy-integrating detector dual-energy computed tomography (DECT) for evaluation of suspected small gastrointestinal lesions. Eligible patients were matched 1:1 with the prospective PCCT cohort using propensity score matching for diagnostic performance comparison.

Diagnostic Test: Contrast-Enhanced Energy-Integrating Detector Dual-Energy Computed Tomography

Prospective Clinical Implementation Cohort

Consecutive adults undergoing routine contrast-enhanced abdominal photon-counting computed tomography (PCCT) in clinical practice. Patients with CT-positive findings suggestive of small gastrointestinal lesions were referred for endoscopy when appropriate to evaluate the clinical implementation of PCCT.

Diagnostic Test: Contrast-Enhanced Photon-Counting Computed Tomography

Interventions

Contrast-enhanced abdominal photon-counting computed tomography performed for the detection and characterization of small gastrointestinal lesions.

Also known as: PCCT
PCCT Diagnostic CohortProspective Clinical Implementation Cohort

Contrast-enhanced abdominal energy-integrating detector dual-energy computed tomography performed for comparison of diagnostic performance in detecting and characterizing small gastrointestinal lesions.

Also known as: DECT
DECT Diagnostic Cohort

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study includes two cohorts: a retrospective diagnostic-performance cohort and a prospective clinical implementation cohort. Patients underwent contrast-enhanced photon-counting CT (PCCT) or energy-integrating detector dual-energy CT (DECT) for evaluation of suspected small gastrointestinal lesions in a clinical setting.

You may qualify if:

  • Adults aged 18-80 years.
  • Patients undergoing contrast-enhanced abdominal CT (photon-counting CT or energy-integrating detector dual-energy CT).
  • At least one endoscopically detected or clinically suspected small gastrointestinal lesion.
  • Lesions confirmed or suspected on endoscopy, pathology, or follow-up imaging.
  • Lesions characterized as mucosal thickening or nodular lesions within predefined size criteria (≤2 cm).

You may not qualify if:

  • Prior gastrointestinal surgery affecting target evaluation region.
  • Poor or nondiagnostic CT image quality.
  • Incomplete or unavailable endoscopic or histopathological reference standard.
  • Ambiguous lesion localization on endoscopy or imaging.
  • Severe motion artifacts or inadequate bowel distension affecting diagnostic evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400010, China

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2026

First Posted

August 6, 2026

Study Start

September 18, 2023

Primary Completion

January 9, 2026

Study Completion

May 21, 2026

Last Updated

August 6, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

This study is an observational diagnostic accuracy study based on routinely collected clinical imaging and endoscopic data. Individual participant data will not be publicly shared due to patient privacy protection and institutional data governance restrictions. Only aggregated results will be reported in publications.

Locations